Accelrys Buys HEOS - Analyst Blog
May 18 2012 - 6:30AM
Zacks
Earlier this week,
Accelrys, Inc. (ACCL) declared its purchase of
Web-based Hit Explorer Operating System (HEOS) from drug
manufacturing company, SCYNEXIS, Inc. This completed the contract
entered into by both parties in 2011 for the marketing of HEOS
using Accelrys’ Cheminformatics Suite of software applications.
The HEOS Software-as-a-Service
(SaaS) platform induces better management and brings forth advanced
research tools which provide celerity to drug development and
discovery. These include biological assay results, advanced
analytical tools and historical data access. Not only do these
features come in a flexible and secure solution package, but are
also immensely user-friendly and affordable.
Accelrys shall be able to
ameliorate its research development procedures and also address a
larger scientific forum using the HEOS package. Hence, market share
proliferation and goodwill enhancement seem to be on the cards for
the company through this integration.
The company has maintained a
proactive stance with regard to escalating product standards and
opting for technological advancements. In its first quarter
financial results declared on May 3, 2012, the company reported a
64% annual hike in expenses accrued for product development to
reach $0.38 million in the quarter. It is praiseworthy that
Accelrys is wholeheartedly devoted to enhancing and developing its
product portfolio even in times of clouded macro conditions.
However, there are companies which
threaten Accelrys’ formidable industry position at all times. These
include big players such as MSCI Inc. (MSCI),
RealPage, Inc. (RP) and Guidewire
Software, Inc. (GWRE).
The company currently retains a
Zacks #2 Rank, which translates into a short-term ‘Buy’ rating.
However, we presently maintain our ‘Neutral’ recommendation on the
stock.
ACCELRYS INC (ACCL): Free Stock Analysis Report
GUIDEWIRE SFTWR (GWRE): Free Stock Analysis Report
MSCI INC-A (MSCI): Free Stock Analysis Report
REALPAGE INC (RP): Free Stock Analysis Report
To read this article on Zacks.com click here.
Zacks Investment Research
Accelrys, Inc. (MM) (NASDAQ:ACCL)
Historical Stock Chart
From Jun 2024 to Jul 2024
Accelrys, Inc. (MM) (NASDAQ:ACCL)
Historical Stock Chart
From Jul 2023 to Jul 2024